Topics

Latest "Aptar Pharma" News Stories

00:32 EDT 22nd August 2019 | BioPortfolio

Here are the most relevant search results for "Aptar Pharma" found in our extensive news archives from over 250 global news sources.

More Information about Aptar Pharma on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Aptar Pharma for you to read. Along with our medical data and news we also list Aptar Pharma Clinical Trials, which are updated daily. BioPortfolio also has a large database of Aptar Pharma Companies for you to search.

Showing "Aptar Pharma" News Articles 1–25 of 7,400+

Wednesday 21st August 2019

5 Top Gainers In Healthcare Sector (HARP, NXTC, TPTX.)

The following are some of today's top gainers in the pharma/biotech sector.


NHS England to fund Hemlibra for patients with severe haemophilia http://bit.ly/2MvwrXG  #pharma #hemophiliapic.twitter.com/QW9cVEsFkG

NHS England to fund Hemlibra for patients with severe haemophilia http://bit.ly/2MvwrXG  #pharma #hemophilia pic.twitter.com/QW9cVEsFkG

NHS patients to receive AbbVie's Skyrizi for #PlaquePsoriasis following NICE recommendation http://bit.ly/31SmozB  #psoriasis #pharmapic.twitter.com/nvJniqgo83

NHS patients to receive AbbVie's Skyrizi for #PlaquePsoriasis following NICE recommendation http://bit.ly/31SmozB  #psoriasis #pharma pic.twitter.com/nvJniqgo83


Teva launch generic version of #EpiPen for children http://bit.ly/2znY0df  #pharmapic.twitter.com/lGSLUAKQ9G

Teva launch generic version of #EpiPen for children http://bit.ly/2znY0df  #pharma pic.twitter.com/lGSLUAKQ9G

Glass House Group, One of the Most Quickly Expanding, Privately Held, Vertically Integrated Cannabis and Hemp Companies, Appoints Board Members

Entrepreneur/Private Investor Steve Ruchefsky and Co-Founder of Magu Capital Jocelyn Rosenwald to Leverage Years of Diverse Experience across the Financial, Business, Healthcare and Cannabis Sectors to Support the Company’s Growth Glass House Group, one of the most quickly expanding, privately held, vertically integrated cannabis and hemp companies, announced the appointment of two new board m...

AstraZeneca's Imfinzi flops in advanced treatment-naive non-small cell #LungCancer http://bit.ly/30nAWa9  #pharma #cancerpic.twitter.com/Tdn7hbP8AC

AstraZeneca's Imfinzi flops in advanced treatment-naive non-small cell #LungCancer http://bit.ly/30nAWa9  #pharma #cancer pic.twitter.com/Tdn7hbP8AC

Novartis exec pushed out over Zolgensma data scandal denies wrongdoing http://bit.ly/2KJsDQy  #pharmapic.twitter.com/sZKYDqU0PN

Novartis exec pushed out over Zolgensma data scandal denies wrongdoing http://bit.ly/2KJsDQy  #pharma pic.twitter.com/sZKYDqU0PN

#news #biotech Building a human brain ‘parts list’ for better treatments

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Building a human brain ‘parts list’ for better treatments .A research team led by the Allen Institute for Brain Science has created a “parts list” of the human … Continue reading →

DZ Bank hebt fairen Wert für Bayer auf 69 Euro - 'Halten'

Die DZ Bank hat den fairen Wert je Aktie von Bayer von 57 auf 69 Euro angehoben, aber die Einstufung auf "Halten" belassen. Der Pharma und Agrarchemiekonzern habe das angekündigte Veräußerungsprog...

This fall, we’re bringing STAT’s award-winning coverage to life and assembling top biotech, pharma, and life sciences executives, researchers, health care policymakers, and patient advocates for our inaugural #STATSummit. Learn more about the event h

This fall, we’re bringing STAT’s award-winning coverage to life and assembling top biotech, pharma, and life sciences executives, researchers, health care policymakers, and patient advocates for our inaugural #STATSummit. Learn more about the event here: https://buff.ly/31RpK5X 

NHS England to fund Hemlibra for patients with severe haemophilia http://bit.ly/2MvwrXG  #pharma #hemophiliapic.twitter.com/021uXeZYni

NHS England to fund Hemlibra for patients with severe haemophilia http://bit.ly/2MvwrXG  #pharma #hemophilia pic.twitter.com/021uXeZYni

Pharma industry deals in July 2019 total $4.57bn globally

Total pharma industry deals for July 2019 worth $4.57bn were announced globally, according to GlobalData’s deals database. Embed this chart...Read More... The post Pharma industry deals in July 2019 total $4.57bn globally appeared first on Pharmaceutical Technology.

Evolving your Medical Data Review – SaaS for Patient Safety, Upcoming Webinar Hosted by Xtalks

With mounting pressures to complete trials quicker while reviewing more data than ever before, medical monitors and information technology personnel need a better system for performing medical data review. In this webinar, learn about an effective SaaS solution from industry experts Dr. Anthony Todd Everhart, Consultant at aequanimitas, llc and Rob Rittberg, Clinical Analytics Lead at PerkinElmer....

Vistin Pharma ASA: Invitation to Q2 conference call

Oslo, Norway, 21 August 2019 Vistin Pharma ASA will release its second quarter 2019 results on Thursday 29 August, 2019. Vistin Pharma will host a conference call for all shareholders and intereste...

NHS patients to receive AbbVie's Skyrizi for #PlaquePsoriasis following NICE recommendation http://bit.ly/31SmozB  #psoriasis #pharmapic.twitter.com/K9C9HsW7js

NHS patients to receive AbbVie's Skyrizi for #PlaquePsoriasis following NICE recommendation http://bit.ly/31SmozB  #psoriasis #pharma pic.twitter.com/K9C9HsW7js

Teva launch generic version of #EpiPen for children http://bit.ly/2znY0df  #pharmapic.twitter.com/Ct7SZwXCKs

Teva launch generic version of #EpiPen for children http://bit.ly/2znY0df  #pharma pic.twitter.com/Ct7SZwXCKs

FSD Pharma Launches Online Ordering System for Medicinal Cannabis Fulfillment

Orders for medicinal cannabis can be placed on fvpharma.com FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD” or the “Company”) today announced the launch of its online ordering system for the direct fulfillment of medicinal cannabis orders. Through its wholly-owned subsidiary, FV Pharma Inc. (“FV Pharma”), clients with a prescription from a medical practitioner or a regis...

AstraZeneca's Imfinzi flops in advanced treatment-naive non-small cell #LungCancer http://bit.ly/30nAWa9  #pharma #cancerpic.twitter.com/lUSDDbDB13

AstraZeneca's Imfinzi flops in advanced treatment-naive non-small cell #LungCancer http://bit.ly/30nAWa9  #pharma #cancer pic.twitter.com/lUSDDbDB13

Big Pharma Nibbles As Turkey’s Localization Policy Yields Limited Results

The Turkish Government’s carrot-and-stick “localization” policy has started to yield results with some multinational pharma companies including GSK and Sanofi...   

UK Govt Asks: Are Trial Sponsors Ready For No-Deal Brexit?

Pharma firms are being asked to let the government know how prepared they are in terms of ensuring supplies of...  ...

Ra Pharmaceuticals Earns Clinical Development Milestone for Oral Macrocyclic Peptide Candidate Targeting Cardiovascular Indication Under Agreement with Merck

Marks the second compound from Ra’s Extreme Diversity™ platform to enter clinical trials Ra Pharmaceuticals, Inc. (Nasdaq:RARX) today announced that it has earned a clinical development milestone under its collaboration agreement with Merck, known as MSD outside the U.S. and Canada. The milestone is associated with the dosing of the first patient in a Phase 1 clinical trial evaluating an inv...

Purdue Pharma sells North Carolina site to Novo Nordisk

The solid dose manufacturing site will be refurbished to manufacture tablets for oral semaglutide (diabetes treatment) and future oral medicines

Novartis exec pushed out over Zolgensma data scandal denies wrongdoing http://bit.ly/2KJsDQy  #pharmapic.twitter.com/jg7dZgceFp

Novartis exec pushed out over Zolgensma data scandal denies wrongdoing http://bit.ly/2KJsDQy  #pharma pic.twitter.com/jg7dZgceFp

NHS England to fund Hemlibra for patients with severe haemophilia

NHS England is to fund Roche and Chugai Pharma UK’s haemophilia drug Hemlibra, for people with sever congenital haemophilia A without factor VIII inhibitors. read more

Sarepta, Evotec, MorphoSys - das rät aktuell Marion Schlegel

Weitere Videos finden Sie unter: https://www.deraktionaer.tv Marion Schlegel vom Anlegermagazin DER AKTIONÄR blickt in dieser Sendung auf die aktuellen Entwicklungen in der Pharma- und Biotechbranc...


Quick Search

News Quicklinks